Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Items 101–200 of 805
Kaneko, H., Yano, Y., Lee, H., Lee, H., Okada, A., Suzuki, Y., Itoh, H., Matsuoka, S., Fujiu, K., Michihata, N., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.22.00083 · Cited by 33
Clarke, R., Wright, N., Walters, R. G., Gan, W., Guo, Y., Millwood, I. Y., Yang, L., Chen, Y., Lewington, S., Lv, J., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20120 · Cited by 32
Self-citationEijgen, J. V., Melgarejo, J. D., Laeken, J. V., van der Pluijm, C., Matheussen, H., Verhaegen, M., Keer, K. V., Maestre, G. E., Al‐Aswad, L. A., Vanassche, T., et al. (2023) · American Journal of Hypertension · doi:10.1093/ajh/hpad111 · Cited by 34
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension Research · doi:10.1038/s41440-022-01016-w · Cited by 33
Self-citationHeimark, S., Mehlum, M. H., Mancia, G., Søraas, C. L., Liestøl, K., Wachtell, K., Larstorp, A. C. K., Rostrup, M., Mariampillai, J. E., Kjeldsen, S. E., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21454 · Cited by 35
Satoh, M., Muroya, T., Murakami, T., Obara, T., Asayama, K., Ohkubo, T., Imai, Y., & Metoki, H. (2023) · Hypertension Research · doi:10.1038/s41440-023-01452-2 · Cited by 31
Barbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00723 · Cited by 29
Izquierdo, M., Ramírez‐Vélez, R., & Singh, M. F. (2025) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2025.100763 · Cited by 37
Central Adiposity or Hypertension
Packer, M., Butler, J., Lam, C. S. P., Zannad, F. M., Vaduganathan, M., & Borlaug, B. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.036 · Cited by 32
Gaffney, B., Jacobsen, A. P., Pallippattu, A. W., Leahy, N., & McEvoy, J. W. (2021) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s286957 · Cited by 30
Haruhara, K., Kanzaki, G., & Tsuboi, N. (2022) · Hypertension Research · doi:10.1038/s41440-022-01061-5 · Cited by 36
Sharp, A. S. P., Cao, K. N., Esler, M., Kandzari, D. E., Lobo, M. D., Schmieder, R. E., & Pietzsch, J. B. (2024) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcae001 · Cited by 30
Bogaerts, J. M. K., Gussekloo, J., de Jong-Schmit, B. E. M., le Cessie, S., Mooijaart, S. P., van der Mast, R. C., Achterberg, W. P., & Poortvliet, R. K. E. (2024) · Age and Ageing · doi:10.1093/ageing/afae133 · Cited by 30
“Conversely, landmark randomised controlled trials (RCTs) such as HYVET [4], SPRINT [5] and STEP [6] confirm that starting antihypertensive treatment with tight BP control reduces major cardiovascular events and all-cause mortality in adults 75 years of age or older.”
BackgroundNovel pharmacological approaches to lowering blood pressure and managing hypertension
Sayer, M., Webb, D. J., & Dhaun, N. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01131-4 · Cited by 29
Lauder, L., Weber, T., Böhm, M., Brouwers, S., Bruno, R. M., Gerdts, E., Kreutz, R. H., Lüscher, T. F., Mancia, G., McEvoy, J. W., et al. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01187-2 · Cited by 30
Reboldi, G., Angeli, F., Gentile, G., & Verdecchia, P. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.03.032 · Cited by 28
Yu, J., Song, Q., Bai, J., Wu, S., Bu, P., Li, Y., & Cai, J. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20376 · Cited by 24
Self-citationAge-dependent implications of left ventricular hypertrophy regression in patients with hypertension
Chu, H.-W., Hwang, I., Kim, H. M., Park, J., Choi, H., Choi, H., Yoon, Y. E., & Cho, G. (2024) · Hypertension Research · doi:10.1038/s41440-023-01571-w · Cited by 24
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Steffen, H., Bönner, G., & Middeke, M. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2117463 · Cited by 24
Highlights of the 2024 Chinese hypertension guidelines
Liu, J. (2025) · Hypertension Research · doi:10.1038/s41440-024-02070-2 · Cited by 28
Zhang, Y., Song, Y., Lu, Y., Liu, T., & Yin, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1517658 · Cited by 25
Huang, Z., Chen, Z., Wang, X., Ding, X., Cai, Z., Li, W., Cai, Z., Lan, Y., Chen, G., Fang, W., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19633 · Cited by 23
Self-citationChiu, N., Chiu, L., Aggarwal, R., Raber, I., Bhatt, D. L., & Mukamal, K. J. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19882 · Cited by 24
Butel-Simoes, L. E., Haw, T. J., Williams, T. D., Sritharan, S., Gadre, P., Herrmann, S. M., Herrmann, J., Ngo, D. T. M., & Sverdlov, A. L. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.17947 · Cited by 24
Chazova, I. E., Михайловна, Ч. Н., Blinova, N. V., Владимировна, А. А., Alekseeva, T. A., Ambatiello, L. G., Balanova, Y. А., Bragina, A. E., Danilov, N. M., Drapkina, O. M., et al. (2024) · Systemic Hypertension · doi:10.38109/2075-082x-2024-4-5-109 · Cited by 28
Definition, prevalence, and economic impacts of hypertension on the elderly population
Lien, C.-W., Lee, Y., Lu, C., Chang, Y.-C., Lin, Y., Cheng, H., Chen, M. Y., Lee, L., Huang, C.-K., Lin, Y., et al. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.02.020 · Cited by 26
Multiparametric cloth-based wearable, SimpleSense, estimates blood pressure
Kumar, P. S., Rai, P., Ramasamy, M., Varadan, V., & Varadan, V. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-17223-x · Cited by 23
Liao, C., Toh, H. S., Sun, L. J., Yang, C., Hu, A., Wei, D., Melgarejo, J. D., & Zhang, Z. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0708 · Cited by 22
Yang, R., Zhang, X., Bai, J., Wang, L., Wang, W., & Cai, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002863 · Cited by 30
Self-citationAgreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022
Hoshide, S., Yamamoto, K. I., Katsurada, K., Yano, Y., Nishiyama, A., Wang, J., Narasingan, S. N., Verma, N., Erwinanto, E., Turana, Y., et al. (2022) · Hypertension Research · doi:10.1038/s41440-022-00994-1 · Cited by 24
Self-citation2023 Guideline for the management of hypertension in the elderly population in China
Hua, Q., Fan, L., Wang, Z., & Li, J. (2024) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2024.06.001 · Cited by 23
Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults
Montgomery, S., Miedema, M. D., & Dodson, J. A. (2021) · Heart · doi:10.1136/heartjnl-2021-320154 · Cited by 21
O’Donoghue, P., O’Halloran, A. M., Kenny, R. A., & Romero‐Ortuño, R. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101304 · Cited by 25
Evaluating blood pressure targets in chronic kidney disease: a systematic review and meta-analysis
Tada, K., Fujiwara, A., Sugano, N., Hayashi, K., Sakima, A., Takami, Y., Kosuke, M., Arima, H., Arima, S., & Nakagawa, N. (2025) · Hypertension Research · doi:10.1038/s41440-025-02262-4 · Cited by 22
Nolde, J. M., Beaney, T. E., Carnagarin, R., Schutte, A. E., Poulter, N. R., & Schlaich, M. P. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19144 · Cited by 22
Liu, J., Wang, B., Li, Y., Yan, X., Li, J., & Li, J. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.12.003 · Cited by 20
Self-citationHeaton, J. N., Alshami, A., Imburgio, S., Mararenko, A., Schoenfeld, M. S., Sealove, B. A., Asif, A., & Almendral, J. G. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.034322 · Cited by 20
Blood pressure management to prevent recurrent stroke: current evidence and perspectives
Silva, G. S., de Andrade, J. B. C., Martins, E. B., Santo, K., & Machline-Carrion, M. J. (2024) · npj Cardiovascular Health · doi:10.1038/s44325-024-00021-x · Cited by 20
Flack, J. M., Azizi, M., Brown, J. M., Dwyer, J. P., Jones, E. S. W., Lihn, A. S., Liu, L., Olsson, D. S., Perl, S., Shibata, H., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02297-7 · Cited by 24
Risks associated with intensive blood pressure control in older patients
Rivasi, G., Ceolin, L., Capacci, M., Matteucci, G., Testa, G. D., & Ungar, A. (2023) · Kardiologia Polska · doi:10.33963/kp.a2022.0297 · Cited by 21
Kandzari, D. E., Cao, K. N., Ryschon, A. M., Sharp, A. S. P., & Pietzsch, J. B. (2024) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2024.102234 · Cited by 26
“53 This led to the derivation of an “ adjustment factor ” — or relative risk — between study-reported and modeled event rates; an adjustment factor of 1 indicated perfect concordance, above 1 indicated under-projection by the model, and below 1 indicated overprojection by the model.”
Autonomic Nervous System: A Therapeutic Target for Cardiac End-Organ Damage in Hypertension
Gottlieb, L. A., Mahfoud, F., Stavrakis, S., Jespersen, T., & Linz, D. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.19460 · Cited by 23
Haze, T., Katsurada, K., Sakata, S., Kuwabara, M., Nishida, N., Azegami, T., Sakima, A., & Kai, H. (2025) · Hypertension Research · doi:10.1038/s41440-025-02131-0 · Cited by 24
Suzuki, Y., Kaneko, H., Yano, Y., Okada, A., Itoh, H., Matsuoka, S., Yokota, I., Imaizumi, T., Fujiu, K., Michihata, N., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.122.026192 · Cited by 18
Racial and Ethnic Disparities in Primary Prevention of Cardiovascular Disease
Ali, M., Nacer, H., Lawson, C. A., & Khunti, K. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.028 · Cited by 26
“Two further large trials, the St rategy of Blood Pressure Intervention in the E lderly Hypertensive P atients (STEP) study 64 and the S alt S ubstitute a nd S troke S tudy (SSaSS) 65 from China showed that salt substituted with reduced sodium and increased potassium levels reduced hypertension.”
BackgroundManagement of Hypertension in the Asia-Pacific Region: A Structured Review
Rahman, A., Magno, J. D. A., Cai, J., Han, M., Lee, H., Nair, T., Narayan, O. P., Jiampo, P., Minh, H. V., & Khurana, R. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00625-1 · Cited by 22
Self-citationShihab, S., Boucher, R. E., Abraham, N., Wei, G., & Beddhu, S. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18172 · Cited by 18
Time to benefit for stroke reduction after blood pressure treatment in older adults: A meta‐analysis
Ho, V. S., Cenzer, I. S., Nguyen, B. T., & Lee, S. J. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17684 · Cited by 20
Ling, Q., Song, Q., Bai, J., Wu, S., Zhang, W., Chen, M., & Cai, J. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.20022 · Cited by 17
Self-citationTen-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation
Li, W., Li, C., Li, Z., Li, Q., Liu, C., Sun, X., He, Q., Xia, D., Xia, D., & Lu, C. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003650 · Cited by 19
The lowest well tolerated blood pressure: A personalized target for all?
Verdecchia, P., Angeli, F., & Reboldi, G. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.01.025 · Cited by 18
Blood Pressure Estimation by Photoplethysmogram Decomposition into Hyperbolic Secant Waves
Nagasawa, T., Iuchi, K., Takahashi, R., Tsunomura, M., de Souza, R. P., Ogawa‐Ochiai, K., Tsumura, N., & Cardoso, G. C. (2022) · Applied Sciences · doi:10.3390/app12041798 · Cited by 17
Khan, S. S., Lloyd-Jones, D. M., Abdalla, M., Bello, N. A., Blyler, C. A., Carter, J., Commodore-Mensah, Y., Ferdinand, K. C., Johnson, H. M., Jones, D., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.08.001 · Cited by 16
Effect of Intensive Blood Pressure Control on Stroke
Li, J., Lei, L., Li, Y., Zhang, H., Yan, X., Sun, Y. H., He, D., Du, L., Hu, J., Qi, L., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.055 · Cited by 17
Self-citationWu, S., Li, M., Lu, J., Tang, X., Wang, G., Zheng, R., Niu, J., Chen, L., Huo, Y., Xu, M., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.19902 · Cited by 18
Self-citationKario, K., Okawara, Y., Kanegae, H., Tomitani, N., & Hoshide, S. (2024) · Hypertension Research · doi:10.1038/s41440-024-01866-6 · Cited by 16
Self-citationManagement of Elderly Patients with Chronic Kidney Disease
Park, Y., & Hwang, W. M. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2024.0178 · Cited by 17
Wu, S., Wang, Y., Wang, J., Feng, J. H., Li, F., Lin, L., Ruan, C., Nie, Z., Tian, J., & Jin, C. (2025) · BMC Medicine · doi:10.1186/s12916-025-03923-4 · Cited by 17
Self-citationManagement of hypertension in the digital era: Perspectives and future directions
Fujiwara, T., McManus, R. J., & Kario, K. (2022) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2022.01.004 · Cited by 21
Self-citationCurrent topics of frailty in association with hypertension and other medical conditions
Toba, A., & Ishikawa, J. (2023) · Hypertension Research · doi:10.1038/s41440-023-01200-6 · Cited by 17
Liu, X., Steinman, M. A., Lee, S. J., Peralta, C. A., Graham, L. A., Li, Y., Jing, B., Fung, K. Z., & Odden, M. C. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18301 · Cited by 18
Self-citationSTEP to estimate cardiovascular events by home blood pressure in the era of digital hypertension
Kario, K., Sakima, A., & Ohya, Y. (2021) · Hypertension Research · doi:10.1038/s41440-021-00764-5 · Cited by 16
Self-citationNovel Mouse Model of Coronary Atherosclerosis With Myocardial Infarction: Insights Into Human CAD
Chen, H., Wan, Q., Yang, J., Rao, H., Xu, C., Xu, P., Yang, X., Wang, H. Y.-C., Feng, W., Wang, L., et al. (2025) · Circulation Research · doi:10.1161/circresaha.125.326409 · Cited by 18
Self-citationIntensive Blood Pressure Control in Older Patients With Hypertension
Song, Q., Peng, X., Bai, J., Yang, R., Ling, Q., Chen, S., Ji, Y., Dong, X., Wang, X., Wu, S., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.045 · Cited by 15
Self-citationLau, D., Ringrose, J., McAlister, F. A., Fradette, M., Wood, P. W., Boulanger, P., Klarenbach, S. W., Holroyd-Leduc, J. M., Alagiakrishnan, K., Rabi, D. M., et al. (2022) · Journal of Hypertension · doi:10.1097/hjh.0000000000003202 · Cited by 17
Current issues in frailty and hypertension management
Yamamoto, K. I. (2023) · Hypertension Research · doi:10.1038/s41440-023-01310-1 · Cited by 15
Qiu, W., Cai, A., Li, L., & Feng, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02227-w · Cited by 15
Self-citationWeir, M. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15764 · Cited by 18
Khan, S. S., Abdalla, M., Bello, N. A., Blyler, C. A., Carter, J., Commodore-Mensah, Y. Y., Ferdinand, K. C., Johnson, H. M., Jones, D. W., Khera, A., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000248 · Cited by 18
Heart failure in China: a macroeconomic modelling study of intervention strategies
Wang, H., Zhou, H., Chai, K., Yan, S., Liu, Y., Kühn, M., Klaus Prettner, A., Cao, Z., Du, M., Wang, T., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf992 · Cited by 15
Self-citationSeidu, S., Sathanapally, H., Kunutsor, S. K., & Khunti, K. (2023) · Journal of the Royal Society of Medicine · doi:10.1177/01410768231156997 · Cited by 17
Yan, Y., Han, Y., Liu, B., Du, J. C., Wang, J., Jing, X., Liu, Y., Deng, S., Du, J., Li, Y., et al. (2023) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2023.0008 · Cited by 17
Self-citationLi, X.-T., Zhang, J., Xing, Z., Liu, Q., Zhou, S., & Xiao, Y. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.04.009 · Cited by 15
Pajewski, N. M., Beddhu, S., Bress, A. P., Chang, T. I., Chertow, G. M., Cheung, A. K., Cushman, W. C., Freedman, B. I., Greene, T., Johnson, K., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000459 · Cited by 14
Abe, M., Segawa, H., Kinguchi, S., Satoh, A., Zamami, R., Nishikido, T., Tanaka, A., Ohnishi, H., Node, K., Saitoh, S., et al. (2025) · Hypertension Research · doi:10.1038/s41440-025-02209-9 · Cited by 15
Chun, S., Han, K., Lee, S., Cho, M. H., Jeong, S., Jung, H., Son, K. Y., Shin, D. W., & Lee, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030418 · Cited by 14
Razavi, A. C., Allen, N. B., Dzaye, O. D. A., Michos, E. D., Budoff, M. J., Lima, J. A. C., Shikany, J. M., Liu, K., Post, W. S., Blumenthal, R. S., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.08.022 · Cited by 14
Zheutlin, A. R., Addo, D. K., Jacobs, J. A., Derington, C. G., Herrick, J. S., Greene, T., Stulberg, E. L., Berlowitz, D. R., Williamson, J. D., Pajewski, N. M., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21323 · Cited by 14
Kristensen, A. M. D., Pareek, M., Kragholm, K. H., Sehested, T. S. G., Olsen, M. H., & Prescott, E. (2022) · Cardiology · doi:10.1159/000524948 · Cited by 18
Jang, Y., Seo, J.-M., Ihm, S., Lee, H., & on behalf of the Korean Society of Hypertension (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00242-9 · Cited by 13
Impact of Hypertension Duration on the Cardiovascular Benefit of Intensive Blood Pressure Control
Ling, Q., Dong, X., Bai, J., Deng, Y., Song, Q., & Cai, J. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23439 · Cited by 15
Self-citationNarita, K., Shimbo, D., & Kario, K. (2024) · Hypertension Research · doi:10.1038/s41440-024-01844-y · Cited by 14
Self-citationHigher blood pressure targets for hypertension in older adults
Falk, J., Froentjes, L. S., Kirkwood, J. E. M., Heran, B. S., Kolber, M. R., Allan, G. M., Korownyk, C. S., & Garrison, S. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011575.pub3 · Cited by 22
Jamshidian, M. S., Scherzer, R., Estrella, M. M., Kravitz, R. L., Boxer, R. S., Tancredi, D. J., Berry, J. D., de Lemos, J. A., Ginsberg, C., Ix, J. H., et al. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19395 · Cited by 14
Nozato, Y., Nohara‐Shitama, Y., Kubozono, T., Akasaka, H., Takami, Y., Arima, H., Sakima, A., & Yamamoto, K. I. (2025) · Hypertension Research · doi:10.1038/s41440-025-02302-z · Cited by 14
Antihypertensive medication in frail older adults: A narrative review through a deprescribing lens
Kraut, R. Y., Lundby, C., Бабенко, О., Kamal, A., & Sadowski, C. A. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100166 · Cited by 17
“[16] Including ambulatory community-dwelling older adults does not exclude the possibility of a frail senior, but it does make it far less likely.”
BackgroundmiR-21 upregulation exacerbates pressure overload-induced cardiac hypertrophy in aged hearts
Chang, W., Shih, J., Lin, Y., Huang, T.-L., Chen, Z., Chen, C., Chu, J., & Liu, P. Y. (2022) · Aging · doi:10.18632/aging.204194 · Cited by 13
Tawfik, Y. M. K., Tassell, B. W. V., Dixon, D. L., Baker, W. L., Fanikos, J. R., & Buckley, L. F. (2023) · Diabetes Care · doi:10.2337/dc22-2040 · Cited by 12
Epidemiology of Hypertension in Older Adults
Chaitoff, A. M., & Zheutlin, A. R. (2024) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2024.04.007 · Cited by 13
Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions
Dalakoti, M., Lin, N. H. Y., Yap, J. J. L., Cader, F. A., Prajapati, D., Lee, D. P. H., Shariff, R. E. R., Cuenza, L. R., Honda, S., Malis, V., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101676 · Cited by 15
Self-citationNew Trends in the Diagnosis and Management of Hypertension
Tinawi, M. (2022) · Cureus · doi:10.7759/cureus.22393 · Cited by 14
A novel methodological framework was described for detecting and quantifying overdiagnosis
Bell, K., Doust, J. A., Sanders, S., Buchbinder, R., Glasziou, P., Irwig, L., Jones, M., Moynihan, R. N., Kazda, L., & Barratt, A. L. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.04.022 · Cited by 12
Wang, A., Tian, X., Zuo, Y., Chen, S., Zhang, Y., Zhang, X., Deng, X., Xu, Q., Wang, P., Wu, S., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19587 · Cited by 13
Self-citationSuzuki, Y., Kaneko, H., Yano, Y., Okada, A., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., Morita, H., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac278 · Cited by 12
Cardiovascular Risk Management in Persons with Dementia
Nijskens, C. M., Henstra, M. J., Rhodius‐Meester, H. F. M., Yaşar, S., van Poelgeest, E. P., Peters, M. J. L., & Muller, M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230019 · Cited by 12
Wang, M. C., Petito, L. C., Pool, L. R., Foti, K. E., Juraschek, S. P., McEvoy, J. W., Nambi, V., Carnethon, M. R., Michos, E. D., & Khan, S. S. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.04.011 · Cited by 12
Trimarco, V., Manzi, M. V., Izzo, R., Mone, P., Lembo, M., Pacella, D., Esposito, G., Falco, A., Morisco, C., Gallo, P., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1137706 · Cited by 12
Yang, R., Zhang, J., Yu, X., Yang, G., & Cai, J. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae001 · Cited by 12
Self-citationUnexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Neppala, S., Rajan, J., Yang, E., & DeFronzo, R. A. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02055-0 · Cited by 12
Deng, Y., Bai, J., Yang, X., Liu, W. Y., Guo, Z., Zhang, J., Huang, R., Yang, X., Yu, C., Yu, J., et al. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad142 · Cited by 12
Self-citation
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.